COL1A1 rs4884227: Ligament and Tendon Biology
The genetic variant rs4884227 is a single nucleotide polymorphism located in an intronic region of the COL1A1 gene on chromosome 17. Research in exercise genomics has explored its statistical associations with soft tissue mechanics, tendon tensile stiffness, and the relative risk of cruciate ligament rupture in athletic cohorts. However, published scientific evidence remains preliminary, with modest effect sizes that do not determine individual injury outcomes.
What each genotype means
Typical ligament and tendon stiffness
You carry two copies of the common C allele for this COL1A1 intronic marker. In candidate gene investigations, this baseline genotype represents typical structural collagen fibril characteristics and standard connective tissue injury risk. However, published scientific evidence linking this specific locus to cruciate ligament rupture or mechanical tendon stiffness remains limited and exploratory.
Carried by approximately 60% to 65% of individuals of European ancestry and common globally.
Intermediate connective tissue elasticity profile
You have one copy of the C allele and one copy of the T allele for this COL1A1 variant. Preliminary athletic cohort research suggests that carrying the T allele may correlate with variations in tendon stiffness and anterior cruciate ligament injury rates. Because published findings are based on small candidate-gene studies and overall evidence is limited, this result does not establish an elevated injury risk on its own.
Carried by roughly 30% to 35% of people of European descent.
Altered tendon stiffness marker
You carry two copies of the less common T allele for this COL1A1 variant. Some sports performance studies have investigated this genotype for potential differences in soft-tissue elasticity, tensile properties, and susceptibility to cruciate ligament tears. Evidence for these associations remains limited and inconsistent across broader populations, so lifestyle, conditioning, and biomechanics remain the primary drivers of joint health.
Carried by approximately 3% to 5% of individuals of European ancestry.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism rs4884227 resides within the collagen type I alpha 1 (COL1A1) gene located on human chromosome 17q21.33. As an intronic variant, it lies outside the protein-coding exons of the gene and does not alter the underlying amino acid sequence of the resulting protein chain directly. Instead, intronic single nucleotide polymorphisms are frequently investigated by genomic researchers as non-coding regulatory markers that might modulate transcription factor binding, alter pre-mRNA splicing efficiency, or exist in linkage disequilibrium with other functional variants nearby. Because rs4884227 resides in a tightly coordinated genomic locus, sport geneticists examine it to determine whether subtle alterations in non-coding DNA correlate with inter-individual differences in connective tissue architecture or biomechanical properties across athletic and general populations.
The Biological Role of COL1A1 in Connective Tissue
The COL1A1 gene encodes the pro-alpha1(I) chain of type I collagen, the principal structural extracellular matrix protein in the human body. Type I collagen forms a triple-helix heterotrimer consisting of two alpha1 chains and one alpha2 chain, assembled into durable, cross-linked fibrils. These fibrils provide the tensile strength and structural resilience necessary for dense connective tissues, including bone, skin, tendons, and articular ligaments like the anterior cruciate ligament. Mechanical loading in sports and daily locomotion places immense physical stress on these connective structures. Because type I collagen governs the tensile stiffness and load-bearing tolerance of tendons and ligaments, variations in genes that coordinate collagen synthesis and matrix maintenance have long been primary candidates in research into musculoskeletal health and physical performance.
Current Research Evidence and Rupture Risk
Candidate-gene association studies have evaluated rs4884227 alongside better-characterized COL1A1 markers to examine associations with tendon stiffness and cruciate ligament injuries. Some observational studies reported statistically significant associations between specific alleles and altered rates of anterior cruciate ligament rupture or differences in tendon tensile properties among athletic cohorts. However, the overall strength of this scientific evidence is categorized as limited. Soft tissue injuries are complex, polygenic phenotypes influenced by hundreds of small-effect variants alongside biomechanical, training, and environmental factors. Many genetic associations identified in small sports cohorts fail to achieve genome-wide significance in large-scale genome-wide association studies or yield inconsistent results across independent replication trials, meaning rs4884227 cannot be viewed as a definitive causal variant.
Population Distribution and Ancestry Patterns
The frequency of rs4884227 alleles varies across worldwide ancestral groups represented in global reference databases like the Genome Aggregation Database and dbSNP. In cohorts of European ancestry, the minor allele frequency is approximately 0.20, making the minor allele relatively common in this demographic. Heterozygous and homozygous genotypes are both regularly encountered in population sampling. Because the majority of sports genomics studies investigating rs4884227 and related collagen markers have been conducted predominantly in European and Caucasian cohorts, researchers caution against extrapolating statistical correlations to other ancestries. Allele distributions, background linkage disequilibrium patterns, and environmental exposures differ across worldwide populations, underscoring the ongoing need for diverse and larger cohort investigations.
Practical Implications and Clinical Perspective
Having a specific genotype at rs4884227 does not diagnose an injury, predict future ligament rupture, or guarantee structural protection against tendon sprains. Athletic injuries arise from a dynamic interplay of biomechanics, neuromuscular control, conditioning, fatigue, surface conditions, and high-impact physical forces. While commercial genetic testing kits may highlight markers like rs4884227 under sports performance or injury predisposition categories, this genetic information carries no established clinical utility for changing medical care or screening protocols. Proven injury risk reduction strategies—such as neuromuscular training programs, structured strength conditioning, adequate recovery, and proper biomechanical form—remain universally beneficial regardless of an individual's genetic profile.
How common is this variant?
The minor allele at rs4884227 occurs at a frequency of approximately 0.20 in European cohorts, with genotype frequencies distributed across worldwide populations documented in standard genomic catalogs such as dbSNP and gnomAD.
Frequently asked questions
Can rs4884227 predict whether I will tear my ACL?
No, this genetic variant cannot predict whether you will experience an anterior cruciate ligament tear. Ligament injuries result from acute mechanical trauma, landing mechanics, movement patterns, and conditioning, with individual genetic variants contributing only minute statistical effects.
Does this genetic variant change the structure of type I collagen?
Because rs4884227 is an intronic variant, it does not alter the amino acid sequence of the type I collagen protein. Any potential biological influence would occur through indirect gene expression or regulatory mechanisms, which remain unproven for this specific marker.
Should I modify my exercise routine based on my rs4884227 genotype?
No modifications to an exercise routine are recommended solely based on rs4884227 results. Standard neuromuscular training, eccentric strength building, and balanced conditioning provide proven musculoskeletal benefits for all individuals regardless of their genetic test results.
Why is scientific evidence for rs4884227 considered limited?
Most findings derive from small candidate-gene studies in specific athlete groups, which often suffer from low statistical power and variable replication. Large-scale genome-wide association studies have not confirmed rs4884227 as a primary driver of soft tissue ruptures.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4884227?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in COL1A1
This SNP is linked to an age-protective methylation marker in collagen genes, influencing perceived facial aging.
The Sp1 binding site polymorphism in COL1A1 has been extensively studied for associations with bone mineral density (BMD) and fracture risk, though results remain inconsistent across different populations.
An intronic Sp1 transcription factor binding-site variant (often termed the +1245 G/T or Sp1 polymorphism) that influences type I collagen alpha-1 chain synthesis, impacting tendon elasticity, cruciate ligament tear risk, and bone mineral density under mechanical loading.
Regulates Sp1 binding affinity within the COL1A1 regulatory promoter, modulating baseline bone mineral density and connective tissue flexibility traits.
A promoter polymorphism (-1997G/T) in type I collagen alpha 1 that regulates transcriptional activity and alters susceptibility to anterior cruciate ligament ruptures and tendon pathology.
Variant in COL1A1 linked to dermal matrix elasticity, skin thickness, and vulnerability to dermal wrinkle formation.